Home Pre-Clinical Trials Stanford Scientists Identify Defect Underlying Rheumatoid Arthritis

Stanford Scientists Identify Defect Underlying Rheumatoid Arthritis

230
0
Rheumatoid Arthritis

Bruce Goldman writing for Stanford Medicine reports that a study led by Cornelia Weyand uncovered that shutting down a faulty molecular mechanism in mice could curb the damage caused by rheumatoid arthritis. This pre-clinical investigation holds considerable future translational promise. Follow the link below to read Mr. Goldman’s fascinating article.

Lead Research/Investigator

Cornelia Weyand

https://profiles.stanford.edu/cornelia-weyand

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.